The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Automated cell counters are laboratory instruments used to count and analyze particles or cells such as blood cells in a liquid sample using electrical impedance or fluorescence microscopy methods. Advantages include accuracy, consitency and removing human errors from manual counting.
Market key trends:
One of the key trends in the automated cell counters market is the increasing preference for cell counting automation. Manual methods are time consuming and labor intensive. Automated cell counters offer higher throughput, specificity, sensitivity and reproducibility. They help in standardizing cell counting protocols. Advancements like artificial intelligence integrated cell counters also aid in classifying different cell types automatically thus fueling the growth of this segment in the overall market.
Segment Analysis
The global automated cell counters market is segmented by product type, application type, end-user, and geography. Based on product type, the market is divided into flow cytometers and hemocytometers. Among these, the flow cytometers segment held the largest market share in 2023 owing to its advantages such as high-speed counting and characterization of cells. By application type, the market is bifurcated into research applications and clinical diagnostics. The clinical diagnostics segment currently dominates the market due to increasing demand for automated cell counter products for disease diagnosis and treatment monitoring in hospitals and diagnostic laboratories.
Key Takeaways
The global automated cell counters market is expected to witness high growth, exhibiting CAGR of 7.0% over the forecast period, due to increasing prevalence of chronic and infectious diseases.
Regionally, North America dominated the global market in 2023 supported by high adoption of automated cell counter instruments in clinical research and diagnostic laboratories in the region. Asia Pacific is expected to witness fastest growth over the forecast period owing to rising healthcare spending, increasing R&D investments for cell-based research, and growing clinical diagnostic industry in countries such as China and India.
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. Thermo Fisher Scientific currently dominates the market owing to its wide product portfolio and global market presence.
No comments:
Post a Comment